Literature DB >> 18184861

Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.

Rui Zeng1, Ying Yao, Min Han, Xiaoqin Zhao, Xiao-Cheng Liu, Juncheng Wei, Yun Luo, Juan Zhang, Jianfeng Zhou, Shixuan Wang, Ding Ma, Gang Xu.   

Abstract

Chronic hypoxia in the renal parenchyma is thought to induce epithelial-to-mesenchymal transition (EMT), leading to fibrogenesis and ultimately end-stage renal failure. Biliverdin reductase, recently identified as a serine/threonine/tyrosine kinase that may activate phosphatidylinositol 3-kinase (PI3K) and Akt, is upregulated in response to reactive oxygen species that may accompany hypoxia. We investigated this potential role of biliverdin reductase in hypoxia-induced renal tubular EMT. Expression of biliverdin reductase was upregulated in a human proximal tubule cell line (HK-2) cultured in hypoxic conditions (1% O2), and this was accompanied by reduced expression of E-cadherin and increased expression of the mesenchymal marker vimentin. Inhibiting PI3K reversed these changes, consistent with EMT. In normoxic conditions, overexpression of biliverdin reductase promoted similar characteristics of EMT, which were also reversed by inhibiting PI3K. Furthermore, using small interfering RNA (siRNA) to knockdown biliverdin reductase, we demonstrated that the enzyme associates with phosphorylated Akt and mediates the hypoxia-induced EMT phenotype. In vivo, expression of biliverdin reductase increased in the tubular epithelia of 5/6-nephrectomized rats, and immunohistochemistry of serial sections demonstrated similar localization of phosphorylated Akt and biliverdin reductase. In conclusion, biliverdin reductase mediates hypoxia-induced EMT through a PI3K/Akt-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184861      PMCID: PMC2396754          DOI: 10.1681/ASN.2006111194

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

Review 1.  Transdifferentiation comes of age.

Authors:  F Strutz; G A Müller
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

Review 2.  Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2005-11-16       Impact factor: 10.121

3.  Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

Authors:  J M Fan; Y Y Ng; P A Hill; D J Nikolic-Paterson; W Mu; R C Atkins; H Y Lan
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

4.  Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion.

Authors:  T L Vanden Hoek; C Li; Z Shao; P T Schumacker; L B Becker
Journal:  J Mol Cell Cardiol       Date:  1997-09       Impact factor: 5.000

Review 5.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

Review 6.  New insights into biliverdin reductase functions: linking heme metabolism to cell signaling.

Authors:  Mahin D Maines
Journal:  Physiology (Bethesda)       Date:  2005-12

7.  Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.

Authors:  Y Y Ng; T P Huang; W C Yang; Z P Chen; A H Yang; W Mu; D J Nikolic-Paterson; R C Atkins; H Y Lan
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

8.  Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity.

Authors:  Nicole Lerner-Marmarosh; Jenny Shen; Michael D Torno; Anatoliy Kravets; Zhenbo Hu; Mahin D Maines
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

9.  Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.

Authors:  Tihomir Miralem; Zhenbo Hu; Michael D Torno; Katherine M Lelli; Mahin D Maines
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

10.  Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats.

Authors:  Bin Zhang; Xinling Liang; Wei Shi; Zhiming Ye; Chaosheng He; Xiangming Hu; Shuangxin Liu
Journal:  Nephrology (Carlton)       Date:  2005-08       Impact factor: 2.506

View more
  32 in total

Review 1.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

2.  PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.

Authors:  Edita Aksamitiene; Boris N Kholodenko; Walter Kolch; Jan B Hoek; Anatoly Kiyatkin
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

3.  Impaired wound healing in hypoxic renal tubular cells: roles of hypoxia-inducible factor-1 and glycogen synthase kinase 3β/β-catenin signaling.

Authors:  Jianping Peng; Ganesan Ramesh; Lin Sun; Zheng Dong
Journal:  J Pharmacol Exp Ther       Date:  2011-10-18       Impact factor: 4.030

4.  Role of protein kinase C in advanced glycation end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells.

Authors:  Shuwang Ge; Rui Zeng; Yun Luo; Lin Liu; Honglan Wei; Juan Zhang; Huan Zhou; Gang Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

5.  Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Terry D Hinds; Katherine A Burns; Peter A Hosick; Lucien McBeth; Andrea Nestor-Kalinoski; Heather A Drummond; Abdulhadi A AlAmodi; Michael W Hankins; John P Vanden Heuvel; David E Stec
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

6.  Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice.

Authors:  Guangzhi Chen; Peihua Wang; Gang Zhao; Gang Xu; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-30       Impact factor: 3.072

Review 7.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

8.  Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha.

Authors:  Delphine Goven; Anne Boutten; Véronique Leçon-Malas; Joëlle Marchal-Sommé; Paul Soler; Jorge Boczkowski; Marcel Bonay
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  Preischemic Administration of Nonexpanded Adipose Stromal Vascular Fraction Attenuates Acute Renal Ischemia/Reperfusion Injury and Fibrosis.

Authors:  Liuhua Zhou; Luwei Xu; Jiangwei Shen; Qun Song; Ran Wu; Yuzheng Ge; Hui Xin; Jiageng Zhu; Jianping Wu; Ruipeng Jia
Journal:  Stem Cells Transl Med       Date:  2016-06-30       Impact factor: 6.940

10.  Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.

Authors:  Jun-Shan Ruan; Yu-Ping Liu; Lei Zhang; Ling-Geng Yan; Fang-Tian Fan; Cun-Si Shen; Ai-Yun Wang; Shi-Zhong Zheng; Shao-Ming Wang; Yin Lu
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.